Matches in Wikidata for { <http://www.wikidata.org/entity/Q54262056> ?p ?o ?g. }
- Q54262056 description "2015 nî lūn-bûn" @default.
- Q54262056 description "2015年の論文" @default.
- Q54262056 description "2015年学术文章" @default.
- Q54262056 description "2015年学术文章" @default.
- Q54262056 description "2015年学术文章" @default.
- Q54262056 description "2015年学术文章" @default.
- Q54262056 description "2015年学术文章" @default.
- Q54262056 description "2015年學術文章" @default.
- Q54262056 description "2015年學術文章" @default.
- Q54262056 description "2015年學術文章" @default.
- Q54262056 description "2015年學術文章" @default.
- Q54262056 description "2015年學術文章" @default.
- Q54262056 description "2015年學術文章" @default.
- Q54262056 description "2015년 논문" @default.
- Q54262056 description "article científic" @default.
- Q54262056 description "article scientific" @default.
- Q54262056 description "article scientifique (publié 2015)" @default.
- Q54262056 description "articol științific" @default.
- Q54262056 description "articolo scientifico" @default.
- Q54262056 description "artigo científico (publicado na 2015)" @default.
- Q54262056 description "artigo científico (publicado na 2015)" @default.
- Q54262056 description "artigo científico" @default.
- Q54262056 description "artikull shkencor" @default.
- Q54262056 description "artikulong pang-agham" @default.
- Q54262056 description "artykuł naukowy" @default.
- Q54262056 description "artículo científico publicado en 2015" @default.
- Q54262056 description "artículu científicu" @default.
- Q54262056 description "bilimsel makale" @default.
- Q54262056 description "bài báo khoa học" @default.
- Q54262056 description "mokslinis straipsnis" @default.
- Q54262056 description "naučni članak" @default.
- Q54262056 description "scienca artikolo" @default.
- Q54262056 description "scientific article" @default.
- Q54262056 description "teaduslik artikkel" @default.
- Q54262056 description "tieteellinen artikkeli" @default.
- Q54262056 description "tudományos cikk" @default.
- Q54262056 description "vedecký článok" @default.
- Q54262056 description "vetenskaplig artikel" @default.
- Q54262056 description "videnskabelig artikel (udgivet 2015)" @default.
- Q54262056 description "vitenskapelig artikkel" @default.
- Q54262056 description "vitskapeleg artikkel" @default.
- Q54262056 description "vědecký článek" @default.
- Q54262056 description "wetenschappelijk artikel" @default.
- Q54262056 description "wissenschaftlicher Artikel" @default.
- Q54262056 description "επιστημονικό άρθρο" @default.
- Q54262056 description "мақолаи илмӣ" @default.
- Q54262056 description "мақолаи илмӣ" @default.
- Q54262056 description "наукова стаття, опублікована в липні 2015" @default.
- Q54262056 description "научна статия" @default.
- Q54262056 description "научная статья" @default.
- Q54262056 description "научни чланак" @default.
- Q54262056 description "научни чланак" @default.
- Q54262056 description "գիտական հոդված" @default.
- Q54262056 description "מאמר מדעי" @default.
- Q54262056 description "سائنسی مضمون" @default.
- Q54262056 description "مقالة علمية" @default.
- Q54262056 description "مقالهٔ علمی" @default.
- Q54262056 description "২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q54262056 description "บทความทางวิทยาศาสตร์" @default.
- Q54262056 description "სამეცნიერო სტატია" @default.
- Q54262056 name "Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9." @default.
- Q54262056 name "Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9." @default.
- Q54262056 type Item @default.
- Q54262056 label "Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9." @default.
- Q54262056 label "Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9." @default.
- Q54262056 prefLabel "Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9." @default.
- Q54262056 prefLabel "Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9." @default.
- Q54262056 P1433 Q54262056-7669DB33-BA7D-4CBC-A56E-4AC54A9B72B6 @default.
- Q54262056 P1476 Q54262056-EA463C04-9492-48B8-BC17-F5E87ACA4C34 @default.
- Q54262056 P2093 Q54262056-0D82E14C-8A6C-4E58-B0B6-B106AC93FD4F @default.
- Q54262056 P2093 Q54262056-17B8C90C-ED08-4C0F-B075-F079AF4E9368 @default.
- Q54262056 P2093 Q54262056-2B28DED6-6548-4C22-832A-F36C52E0596D @default.
- Q54262056 P2093 Q54262056-393620F1-8D43-4B2D-8F0C-85D07C2EFA61 @default.
- Q54262056 P2093 Q54262056-6930FEE0-DB3B-4C3F-931D-488F233A15CB @default.
- Q54262056 P2093 Q54262056-8F07D9EA-628F-4A1E-ADFD-9C62B84526EA @default.
- Q54262056 P2093 Q54262056-A96A3341-D215-4220-9C03-ADAF0FAD761F @default.
- Q54262056 P2093 Q54262056-B985B06F-B077-494B-A9C8-3BD565788339 @default.
- Q54262056 P2093 Q54262056-D516D2B1-4641-4AF6-A98A-9E95DAF8D87D @default.
- Q54262056 P2093 Q54262056-FC4473CE-09F2-4306-9835-BF0FCFE6BDF5 @default.
- Q54262056 P2860 Q54262056-014D3C72-F3C6-4643-8303-492069BC676E @default.
- Q54262056 P2860 Q54262056-1D47A2DC-6F56-4DC5-91EF-CA845657F356 @default.
- Q54262056 P2860 Q54262056-2A50ECC8-292E-4119-A2C1-24C890266421 @default.
- Q54262056 P2860 Q54262056-4D0A49D1-6167-43D8-9234-B77EFC93D306 @default.
- Q54262056 P2860 Q54262056-59E6B644-D67F-46F0-ADD4-0FCBF048B9C0 @default.
- Q54262056 P2860 Q54262056-5DCC8C79-35CB-474C-AA81-D805BDDA594D @default.
- Q54262056 P2860 Q54262056-603855A0-62AE-4975-A29C-DFDAC3F1E5FC @default.
- Q54262056 P2860 Q54262056-87BDB982-3753-4D0D-B7B4-A9D8C48CE380 @default.
- Q54262056 P2860 Q54262056-8A38FE5E-2FDA-45E5-BAFF-93A0F0640AAD @default.
- Q54262056 P2860 Q54262056-8A60184F-F0C2-47AE-BDBE-E79E9390EFFB @default.
- Q54262056 P2860 Q54262056-8A7ED4A5-65A0-42CB-9A4F-711C64E64EC0 @default.
- Q54262056 P2860 Q54262056-8CB6F8DB-A10B-4B2B-B9BD-1579EDA19E6A @default.
- Q54262056 P2860 Q54262056-965B764A-F9EE-43D0-965B-3FEE234E7C13 @default.
- Q54262056 P2860 Q54262056-A63F2551-67C0-47EC-AB72-2680067D0ADB @default.
- Q54262056 P2860 Q54262056-A7D9DFE1-F7B3-4CD5-889D-D36D1A86BDDA @default.
- Q54262056 P2860 Q54262056-D3BF3642-23F2-4761-838A-4EFEB5779B70 @default.
- Q54262056 P2860 Q54262056-E1A4D624-6BBA-4BC2-AFB5-DB2BB0744ACB @default.
- Q54262056 P2860 Q54262056-F960E37F-B0C2-4A37-9146-4E85CA5F37B8 @default.
- Q54262056 P2860 Q54262056-FED1F870-703B-4BC3-B2F5-B8091FF9DFD6 @default.
- Q54262056 P2888 Q54262056-CA3A744D-06E7-4DA0-9C67-FD17C11AF216 @default.
- Q54262056 P304 Q54262056-47A80167-344A-4A10-A1DF-279B5FFB3B79 @default.